Amorfix Life Sciences
3403 American Drive, Mississauga,
Ontario, Canada, L4V 1T4
Tel: 416-847-6898
info@amorfix.com
Home
Letter From The CEO
Company
Management
Board of Directors
Products
Product Pipeline
Diagnostics
Alzheimer's Disease Dx
ALS
Liver Cancer
Therapeutics
ALS
Cancer
Technologies
Epitope Protection
ProMIS™ and DSE
Services
A
4
Assay Development
Investor Relations
Press Releases 2013
2012
2011
2010
2009
2008
2007
2006
2005
In the News
Events
Financial Results
12-13
11-12
10-11
09-10
08-09
07-08
Careers
Contact
receive news alerts
Investor Relations
Product Pipeline
Events
April 22-25, 2013 : Chicago, IL
2013 BIO International Convention
April 9, 2013 : Washington, DC
American Association for Cancer Research
January 7-9, 2013 : San Francisco, CA
Biotech Showcase™ 2013
Recent Press Releases
Amorfix to investigate lung cancer misfolded proteins for therapeutic intervention
April 25, 2013
View
Amorfix closes second tranche of private placement offering
April 22, 2013
View
View All Press Releases
Public Filings
Financial Results 2012-2013
Download our IR Brochure